18F-FDG标记白细胞PET/CT检出COVID-19康复者侵袭性真菌感染
本文报告一例重症COVID-19康复后持续发热的患者,18F-FDG标记白细胞PET/CT显示放射性示踪剂在小肠和右肺下叶局灶性聚集,随后活检证实为毛霉病。提示对重症COVID-19康复后长期使用糖皮质激素者应警惕继发侵袭性真菌感染,18F-FDG标记白细胞显像有助于定位诊断。
要点
- 重症COVID-19康复者,尤其长期使用糖皮质激素者,易继发细菌和真菌感染。
- 18F-FDG标记白细胞PET/CT可定位感染灶,本例示小肠和右肺下叶局灶性摄取。
- 活检证实毛霉病,提示该显像对侵袭性真菌感染的诊断价值。
核心结论
- 18F-FDG标记白细胞PET/CT可在持续发热的COVID-19康复者中定位侵袭性真菌感染灶,本例活检证实为毛霉病。
研究设计与样本
- 本文为个案报道,描述一例重症COVID-19康复后持续发热患者的诊断过程。
主要发现
- 18F-FDG标记白细胞扫描显示放射性示踪剂在小肠和右肺下叶局灶性聚集。
- 随后进行的活检证实为毛霉病。
临床怎么用
- 对重症COVID-19康复后持续发热、尤其长期使用糖皮质激素的患者,应警惕继发侵袭性真菌感染。
- 18F-FDG标记白细胞PET/CT可作为定位感染灶的影像学手段,引导后续活检。
局限性
- 本文为单一病例报道,结论的普遍适用性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Occurrence of invasive fungal infections has gained significant attention during recent times in patients with COVID-19. Patients with severe form of COVID-19, such as those treated in the intensive care unit with prolonged steroid use, are particularly vulnerable to secondary bacterial and fungal infections. Disseminated systemic mycosis is a life-threatening condition, especially in immunocompromised patients. Here, we report a case of a recovered severe COVID-19 patient, who presented with persistent fever. 18F-FDG-labeled leukocyte scan revealed focal accumulation of radiotracer in the small intestine and right lung lower lobe. Subsequently, performed biopsy revealed mucormycosis.
引用
- Manda D, Sen I, Thakral P, et al. Invasive Fungal Infection in COVID-19-Recovered Patient Detected on 18F-FDG-Labeled Leukocytes PET/CT Scan. Clin Nucl Med. 2022. PMID: 34319959. doi:10.1097/RLU.0000000000003852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。